TRACEY FORTNER: Open Payments
NPI 1487122065 · AUSTELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 19 payments from 10 companies in 2025. Trend: 2023 $141 · 2024 $208 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 1 | $135 |
| AKEBIA THERAPEUTICS INC | 2 | $118 |
| AstraZeneca Pharmaceuticals LP | 1 | $116 |
| Novo Nordisk Inc | 4 | $90 |
| Mallinckrodt Hospital Products Inc. | 3 | $89 |
| Fresenius USA Marketing, Inc. | 3 | $74 |
| ANI Pharmaceuticals, Inc. | 2 | $54 |
| Calliditas Therapeutics US Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: Vafseo, Ozempic, ACTHAR, VELPHORO, PURIFIED CORTROPHIN GEL, TARPEYO, JYNARQUE, JARDIANCE.
Industry payments across GA — which companies pay providers there.
